journal article·2023-02

Multifunctional biomimetic nanoplatform based on photodynamic therapy and DNA repair intervention for the synergistic treatment of breast cancer

Hang Wu, Xiyou Du, Jiangkang Xu, Xinru Kong, Yingying Li, Dongzhu Liu, Xiaoye Yang, Lei Ye, Jianbo Ji, Yanwei Xi, Guangxi Zhai

Acta Biomaterialia· Volume 157
Publisher page

Abstract

Photodynamic therapy (PDT) is a minimally invasive and locally effective treatment method, which has been used in the clinical treatment of a variety of superficial tumors. In recent years, PDT has received extensive attention due to its induction of immunogenic cell death (ICD). However, the repair mechanism of tumor cells and low immune response limit the further development of PDT. To this end, a multifunctional biomimetic nanoplatform 4T1Mem@PGA-Ce6/Ola (MPCO) is developed to co-deliver the photosensitizer Chlorin e6 (Ce6) and Olaparib (Ola) with the function of preventing DNA repair. The nanoplatform shows efficient tumor targeting and cellular internalization properties due to cell membrane camouflage, and Ce6 and Ola produce a significant synergistic anti-tumor effect under laser irradiation. Meanwhile, the nanoplatform can also activate the cyclic guanosine monophosphate-adenosine monophosphate synthase-interferon gene stimulator signaling (cGAS-STING) pathway to produce cytokines. The damage-associated molecular patterns induced by ICD can work with these cytokines to recruit and stimulate the maturation of dendritic cells and induce the systemic anti-tumor immune response. Overall, this multifunctional biomimetic nanoplatform integrating PDT, chemotherapy, and immunotherapy is highlighted here to boost anti-tumor therapy. STATEMENT OF SIGNIFICANCE: Self-repair of DNA damage is the most important reason for the failure of primary tumor eradication and the formation of secondary and metastatic tumors. To address this issue, a multifunctional biomimetic nanoplatform 4T1Mem@PGA-Ce6/Ola (MPCO) was developed to integrate a photosensitizer Chlorine a6 and a poly (ADP-ribose) polymerase inhibitor Olaparib. With tumor targeting ability and controlled release of drugs, the MPCO was expected to enhance tumor immunogenicity and facilitate antitumor immunity through the induction of immunogenic cell death as well as the activation of the cGAS-STING pathway. This study develops a promising combination strategy against tumors and has substantial implications for the prognosis of patients with breast cancer.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · interferon and immune responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Stimuli-sensitive linear–dendritic block copolymer–drug prodrug as a nanoplatform for tumor combination therapy10.1002/adma.202108049 ↗
2. A facile low-dose photosensitizer-incorporated dissolving microneedles-based composite system for eliciting antitumor immunity and the abscopal effect10.1021/acsnano.1c06225 ↗
3. Simple peptide-tuned self-assembly of photosensitizers towards anticancer photodynamic therapy10.1002/anie.201509810 ↗
4. Peptide-based supramolecular assembly drugs toward cancer theranostics10.1080/17425247.2022.2093855 ↗
5. Dual-responsive and ROS-augmented nanoplatform for chemo/photodynamic/chemodynamic combination therapy of triple negative breast cancer10.1021/acsami.1c14135 ↗
6. Smart peptide-based supramolecular photodynamic metallo-nanodrugs designed by multicomponent coordination self-assembly10.1021/jacs.8b04912 ↗
7. Supramolecular nanofibrils formed by coassembly of clinically approved drugs for tumor photothermal immunotherapy
8. γ-PGA-Coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release10.1002/adhm.201400726 ↗
9. Poly(glutamic acid): production, composites, and medical applications of the next-generation biopolymer
10. Injectable double-crosslinked adhesive hydrogels with high mechanical resilience and effective energy dissipation for joint wound treatment
11. Paclitaxel poliglumex (XYOTAX; CT-2103): An intracellularly targeted taxane10.1097/00001813-200503000-00003 ↗
12. Chitosan/γ-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer10.1016/j.biomaterials.2020.120218 ↗
13. Immunogenic cell death and DAMPs in cancer therapy10.1038/nrc3380 ↗
14. Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells10.1038/s41551-020-0599-5 ↗
15. Synthetic lethality in the clinic10.1126/science.aam7344 ↗
16. PARP1: Structural insights and pharmacological targets for inhibition10.1016/j.dnarep.2021.103125 ↗
17. Concurrent olaparib and radiotherapy in patients with triple-negative breast cancer: The Phase 1 olaparib and radiation therapy for triple-negative breast cancer trial
18. Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial10.1016/S1470-2045(22)00369-2 ↗
19. PARP inhibition elicits STING-dependent antitumor immunity in brca1-deficient ovarian cancer10.1016/j.celrep.2018.11.054 ↗
20. ZnS@BSA Nanoclusters potentiate efficacy of cancer immunotherapy
21. FDA Approval summary: olaparib monotherapy or in combination with bevacizumab for the maintenance treatment of patients with advanced ovarian cancer10.1002/onco.13551 ↗
22. Biomimetic nanomedicine toward personalized disease theranostics10.1007/s12274-020-3265-z ↗
23. Biomembrane-functionalized micromotors: biocompatible active devices for diverse biomedical applications
24. Fighting immune cold and reprogramming immunosuppressive tumor microenvironment with red blood cell membrane-camouflaged nanobullets10.1021/acsnano.0c07721 ↗
25. Erythrocyte membrane camouflaged metal–organic framework nanodrugs for remodeled tumor microenvironment and enhanced tumor chemotherapy10.1002/adfm.202107791 ↗
26. Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy10.1016/j.nantod.2020.100986 ↗
27. Platelet-membrane-coated nanoparticles enable vascular disrupting agent combining anti-angiogenic drug for improved tumor vessel impairment10.1021/acs.nanolett.1c00168 ↗
28. Targeted gene silencing in vivo by platelet membrane-coated metal-organic framework nanoparticles10.1126/sciadv.aaz6108 ↗
29. Personalized nanovaccine coated with calcinetin-expressed cancer cell membrane antigen for cancer immunotherapy10.1021/acs.nanolett.1c03004 ↗
30. Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis10.1016/j.biomaterials.2021.120716 ↗
31. Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer10.1016/j.carbpol.2020.117459 ↗
32. Aggregation-induced emission: phenomenon, mechanism and applications10.1039/b904665h ↗
33. Dragonfly-shaped near-infrared AIEgen with optimal fluorescence brightness for precise image-guided cancer surgery10.1016/j.biomaterials.2020.120036 ↗
34. Cancer-cell-biomimetic nanoparticles for targeted therapy of homotypic tumors10.1002/adma.201602173 ↗
35. Biomimetic metal–organic framework nanoparticles for cooperative combination of antiangiogenesis and photodynamic therapy for enhanced efficacy10.1002/adma.201808200 ↗
36. Cancer-cell-membrane-coated nanoparticles with a yolk-shell structure augment cancer chemotherapy10.1021/acs.nanolett.9b03817 ↗
37. NIR-triggerable ROS-responsive cluster-bomb-like nanoplatform for enhanced tumor penetration, phototherapy efficiency and antitumor immunity10.1016/j.biomaterials.2021.121135 ↗
38. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment10.1039/D0NR08757B ↗
39. Photoactivated lysosomal escape of a monofunctional PtII complex Pt-BDPA for nucleus access10.1002/anie.201906203 ↗
40. New combination treatment from ROS-Induced sensitized radiotherapy with nanophototherapeutics to fully eradicate orthotopic breast cancer and inhibit metastasis10.1016/j.biomaterials.2020.120229 ↗
41. Carrier free photodynamic synergists for oxidative damage amplified tumor therapy
42. Targeting the DNA damage response in immuno-oncology: developments and opportunities10.1038/s41568-021-00386-6 ↗
43. γh2AX: A sensitive molecular marker of DNA damage and repair10.1038/leu.2010.6 ↗
44. Branched polymer-based redox/enzyme-activatable photodynamic nanoagent to trigger STING-dependent immune responses for enhanced therapeutic effect10.1002/adfm.202110408 ↗
45. Parp inhibitor efficacy depends on CD8+ T-cell recruitment via intratumoral sting pathway activation in BRCA-deficient models of triple-negative breast cancer10.1158/2159-8290.CD-18-1218 ↗
46. An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination10.1038/s41467-021-25197-z ↗
47. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway10.1016/j.biomaterials.2011.03.052 ↗
48. Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis10.1038/s41467-020-18626-y ↗
49. Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 signal for combined photothermal therapy and cancer immunotherapy10.1016/j.biomaterials.2021.120964 ↗
50. A siRNA-assisted assembly strategy to simultaneously suppress “self” and upregulate “eat-me” signals for nanoenabled chemo-immunotherapy10.1021/acsnano.1c04458 ↗